Literature DB >> 16870974

Effect of subjective reasoning and neurocognition on medication adherence for persons with schizophrenia.

Keiko Maeda1, Kiyoto Kasai, Akira Watanabe, Katsuyo Henomatsu, Mark A Rogers, Nobumasa Kato.   

Abstract

OBJECTIVE: This study investigated the relationship between patients' reasoning about medication adherence and neurocognitive and clinical indices for a treatment-compliant sample of Japanese patients with schizophrenia.
METHODS: Subjective reasoning about medication adherence was assessed by the Rating of Medication Influences (ROMI) scale. General intelligence, executive function, and verbal memory were assessed by the Wechsler Adult Intelligence Scale-Revised, Wisconsin Card Sorting Test, and Rey Auditory Verbal Learning Test, respectively.
RESULTS: Higher prevention scores were associated with lower executive functioning and older age. Influence of others was associated with years of education, medication dosage, and IQ, and medication affinity was associated with education.
CONCLUSIONS: These results suggest that executive functioning, education, and general IQ may all be important factors in individual motivation for medication adherence.

Entities:  

Mesh:

Year:  2006        PMID: 16870974     DOI: 10.1176/ps.2006.57.8.1203

Source DB:  PubMed          Journal:  Psychiatr Serv        ISSN: 1075-2730            Impact factor:   3.084


  6 in total

Review 1.  Measurement of psychiatric treatment adherence.

Authors:  Martha Sajatovic; Dawn I Velligan; Peter J Weiden; Marcia A Valenstein; Gbenga Ogedegbe
Journal:  J Psychosom Res       Date:  2009-07-25       Impact factor: 3.006

2.  Factors Associated with Medication Adherence Among Patients with Severe Mental Disorders in China: A Propensity Score Matching Study.

Authors:  Lei Dou; Lili Hu; Nan Zhang; Henry Cutler; Yan Wang; Shunping Li
Journal:  Patient Prefer Adherence       Date:  2020-07-31       Impact factor: 2.711

3.  Subjective reasons for adherence to psychotropic medication and associated factors among older adults with schizophrenia.

Authors:  Mamta Sapra; Ipsit V Vahia; Pia N Reyes; Paul Ramirez; Carl I Cohen
Journal:  Schizophr Res       Date:  2008-10-11       Impact factor: 4.939

Review 4.  Adherence to Antipsychotic Medication in Bipolar Disorder and Schizophrenic Patients: A Systematic Review.

Authors:  Saínza García; Mónica Martínez-Cengotitabengoa; Saioa López-Zurbano; Iñaki Zorrilla; Purificación López; Eduard Vieta; Ana González-Pinto
Journal:  J Clin Psychopharmacol       Date:  2016-08       Impact factor: 3.153

5.  Antipsychotic medication adherence and preventive diabetes screening in Medicaid enrollees with serious mental illness: an analysis of real-world administrative data.

Authors:  Erica L Stockbridge; Nathaniel J Webb; Eleena Dhakal; Manasa Garg; Abiah D Loethen; Thaddeus L Miller; Karabi Nandy
Journal:  BMC Health Serv Res       Date:  2021-01-18       Impact factor: 2.655

6.  Medication Adherence in a Cross-Diagnostic Sample of Patients From the Affective-to-Psychotic Spectrum: Results From the PsyCourse Study.

Authors:  Sophie-Kathrin Kirchner; Michael Lauseker; Kristina Adorjan; Heike Anderson-Schmidt; Ion-George Anghelescu; Bernhardt T Baune; Monika Budde; Udo Dannlowski; Detlef E Dietrich; Andreas J Fallgatter; Peter Falkai; Christian Figge; Katrin Gade; Urs Heilbronner; Lena Hiendl; Georg Juckel; Janos L Kalman; Farahnaz Klöhn-Saghatolislam; Carsten Konrad; Fabian U Lang; Mojtaba Oraki Kohshour; Sergi Papiol; Daniela Reich-Erkelenz; Jens Reimer; Eva Z Reininghaus; Sabrina K Schaupp; Max Schmauß; Andrea Schmitt; Eva Christina Schulte; Simon Senner; Carsten Spitzer; Thomas Vogl; Jörg Zimmermann; Alkomiet Hasan; Thomas G Schulze; Fanny Senner
Journal:  Front Psychiatry       Date:  2022-01-20       Impact factor: 4.157

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.